International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Int J Mol Med 43: [Related article:] 1331–1342, 2019; DOI: 10.3892/ijmm.2019.4077
Owing to oversights during the production process, a pair of errors were introduced into the above article. First, in the Materials and methods section, Animals and cell lines subsection, on p. 1332, line 12, the sentence starting here should have read as: 'The non-tumorigenic mouse hepatocyte alpha mouse liver 12 (AML12) cell line was purchased from the Shanghai Cell Bank of Chinese Academy of Sciences (Shanghai, China)' (i.e., the abbreviation AML12 was expanded incorrectly). Secondly, the bottom row of data was accidentally omitted from Table I (pertaining to the Suzuki score for liver ischemia/reperfusion injury assessed to be severe).The fifth data row in the Table should have read, from left to right, as follows: Numerical assessment, '4'; Congestion, 'Severe (>60%)'; Vacuolization, 'Severe (>60%)'; and Necrosis, 'Severe (>60%)'.
We regret that these errors were introduced into the published version of this paper, and apologize to the authors and the readership for the inconvenience caused.